Clinical Trial Update: The Safety and Effectiveness of Ritonavir in the Treatment of HIV-Related Kaposi's Sarcoma [Phase 2]

View source ↗

Summary

A completed Phase 2 trial assessing the safety and effectiveness of Ritonavir in HIV-related Kaposi's sarcoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Kaposi Sarcoma

Drugs mentioned

• Norvir (ritonavir)

Snippet

Sponsor: Abbott | Conditions: Sarcoma, Kaposi, HIV Infections | Phase 2 | Status: COMPLETED